Published in Int J Radiat Oncol Biol Phys on November 02, 2006
Carbon ion radiotherapy for sacral chordoma. Br J Radiol (2011) 1.27
Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys (2008) 1.27
Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol (2008) 1.03
Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. Br J Radiol (2013) 0.93
Review of clinical experience with ion beam radiotherapy. Br J Radiol (2011) 0.91
The value of image-guided intensity-modulated radiotherapy in challenging clinical settings. Br J Radiol (2013) 0.79
Proton radiotherapy for pediatric sarcoma. Cancers (Basel) (2014) 0.76
Helical tomotherapy of spinal chordomas: French Multicentric, retrospective study of a cohort of 30 cases. Radiat Oncol (2017) 0.75
Giant chordoma in the thoracolumbar spine: a case report and literature review. Eur Spine J (2016) 0.75
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer (2010) 4.95
A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2009) 2.06
Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol (2004) 1.81
Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys (2002) 1.79
Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging (2008) 1.76
Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys (2004) 1.69
Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience. Radiother Oncol (2011) 1.69
The clinical potential of intensity modulated proton therapy. Z Med Phys (2004) 1.59
Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer (2012) 1.56
Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (2010) 1.46
Radiologic patterns of necrosis after proton therapy of skull base tumors. Can J Neurol Sci (2013) 1.41
Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys (2009) 1.28
Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res (2005) 1.24
Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys (2005) 1.23
Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. Cancer (2013) 1.22
Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys (2008) 1.19
First proton radiography of an animal patient. Med Phys (2004) 1.17
Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys (2003) 1.15
Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys (2007) 1.15
The role of radio- and chemotherapy in glioblastoma. Onkologie (2005) 1.14
Emerging technologies in proton therapy. Acta Oncol (2011) 1.12
Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases. Acta Oncol (2013) 1.11
Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys (2004) 1.11
A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys (2013) 1.07
Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. Int J Radiat Oncol Biol Phys (2011) 1.07
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial. Radiother Oncol (2013) 1.07
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer (2005) 1.06
Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.05
Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys (2004) 1.05
Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol (2008) 1.05
Proton beam therapy interference with implanted cardiac pacemakers. Int J Radiat Oncol Biol Phys (2008) 1.04
Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol (2003) 1.04
Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2009) 1.04
Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer (2009) 1.03
Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba. Int J Radiat Oncol Biol Phys (2010) 1.03
Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2003) 1.02
The water equivalence of solid materials used for dosimetry with small proton beams. Med Phys (2002) 1.01
Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol (2003) 1.01
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys (2010) 1.00
Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study. Radiat Oncol (2011) 0.99
Systematic errors in respiratory gating due to intrafraction deformations of the liver. Med Phys (2007) 0.99
Proton beam therapy of Stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.99
German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlenther Onkol (2007) 0.99
Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer. Radiat Oncol (2012) 0.98
Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys (2010) 0.98
The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys (2009) 0.98
Patient specific optimization of the relation between CT-hounsfield units and proton stopping power with proton radiography. Med Phys (2005) 0.97
Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys (2009) 0.97
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol (2006) 0.96
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning. Radiother Oncol (2010) 0.96
Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial. Radiat Oncol (2014) 0.95
Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol (2010) 0.95
Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute. Int J Radiat Oncol Biol Phys (2008) 0.95
Development of an inorganic scintillating mixture for proton beam verification dosimetry. Phys Med Biol (2004) 0.94
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys (2006) 0.94
Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol (2008) 0.94
Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys (2008) 0.94
Experiences at the Paul Scherrer Institute with a remote patient positioning procedure for high-throughput proton radiation therapy. Int J Radiat Oncol Biol Phys (2008) 0.93
Proton beam therapy for aged patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2007) 0.93
Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys (2004) 0.92
Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast. Radiother Oncol (2002) 0.92
Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys (2011) 0.91
Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol (2003) 0.91
Special report: workshop on 4D-treatment planning in actively scanned particle therapy--recommendations, technical challenges, and future research directions. Med Phys (2010) 0.90
Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer (2006) 0.89
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res (2008) 0.89
Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging. Obstet Gynecol (2002) 0.89
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. Eur J Cancer (2012) 0.88
[Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlenther Onkol (2006) 0.88